Add to Favourites
To login click here
A partnership between Syneos Health and Microsoft aims to use machine learning to improve biopharma companies’ commercial performance and speed up clinical trial processes. The clinical trials market is expected to grow due to factors such as increasing drugs in the pipeline and a rising demand for specialized testing services. Emerging technologies like AI, machine learning, and blockchain are set to revolutionize trial design and data analysis, leading to more efficient and cost-effective processes.